A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
Status:
Completed
Trial end date:
2018-05-21
Target enrollment:
Participant gender:
Summary
This is a single arm, open-label, multi-center study designed to demonstrate the efficacy and
safety of pralatrexate when administered concurrently with vitamin B12 and folic acid
supplementation to patients with relapsed or refractory peripheral T-cell lymphoma(PTCL).
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma (China) Pharmaceutical Co. Ltd
Treatments:
Aminopterin Folic Acid Hydroxocobalamin Vitamin B 12 Vitamin B Complex Vitamins